Filings

4 documents · 27 matches

1. MPLT MapLight Therapeutics, Inc. 10-Q 2026-08-13

   Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

   East, inflation, tariffs and fluctuations in increased interest rates or other factors, on our preclinical and clinical development or operations;
   7 matches in this document Show context Copy citation

2. MPLT MapLight Therapeutics, Inc. 10-Q 2026-05-14

   Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

   East, inflation, tariffs and fluctuations in increased interest rates or other factors, on our preclinical and clinical development or operations;
   7 matches in this document Show context Copy citation

3. MPLT MapLight Therapeutics, Inc. 10-K 2026-03-26

   Item 1. Business.

   tariffs on imported pharmaceutical products; and (4) as part of the Make America Healthy Again Commission’s Strategy Report released
   7 matches in this document Show context Copy citation

4. MPLT MapLight Therapeutics, Inc. 10-Q 2025-12-04

   Item 1A. Risk Factors.

   Middle East, inflation, tariffs and fluctuations in interest rates or other factors, on our preclinical and clinical development or operations;
   6 matches in this document Show context Copy citation